Michael Vasconcelles

Board Member

Equibles does not estimate personal net worth.

About Michael Vasconcelles

Michael Vasconcelles is recorded as Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH) since August 15, 2022. Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed August 17, 2022 that Michael Vasconcelles was appointed Board of Directors, effective August 15, 2022. Dianthus Therapeutics, Inc. /DE/ is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dianthus Therapeutics, Inc. /DE/ includes Marino Garcia (CEO and Board Member), Alison F. Lawton (Chairman), Leon O. Moulder, Jr. (Chairman and Board Member) and 7 others.

“On August 15, 2022, the Board of Directors (the "Board") of Magenta Therapeutics, Inc. (the "Company") unanimously appointed Michael Vasconcelles to the Board.”

Dianthus Therapeutics, Inc. /DE/ Form 8-K, filed August 17, 2022 · Read the filing

Affiliation history

Dianthus Therapeutics, Inc. /DE/ (DNTH)
Board Member

SEC 8-K

Current
2022-08-15–present

Company network

Dianthus Therapeutics, Inc. /DE/

DNTH

Current role

Biotechnology · Healthcare

Board Member

2022-08-15–present

Leadership on record at Dianthus Therapeutics, Inc. /DE/

Marino Garcia CEO, Board Member
Alison F. Lawton Chairman
Leon O. Moulder, Jr. Chairman, Board Member
Ryan Savitz CFO
Steve Mahoney CFO
Adam Veness General Counsel
Edward Carr Chief Accounting Officer
Anne McGeorge Board Member
Jonathan Violin Board Member
Jonathan Violin, Ph.D. Board Member

Recent activity

Executive change Appointed: Board of Directors Dianthus Therapeutics, Inc. /DE/ (DNTH)
2022-08-15